Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dolby Laboratories (DLB) Liabilities and Shareholders Equity (2016 - 2025)

Historic Liabilities and Shareholders Equity for Dolby Laboratories (DLB) over the last 17 years, with Q4 2025 value amounting to $3.2 billion.

  • Dolby Laboratories' Liabilities and Shareholders Equity rose 106.13% to $3.2 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $12.8 billion, marking a year-over-year increase of 454.16%. This contributed to the annual value of $3.2 billion for FY2025, which is 378.89% up from last year.
  • Per Dolby Laboratories' latest filing, its Liabilities and Shareholders Equity stood at $3.2 billion for Q4 2025, which was up 106.13% from $3.2 billion recorded in Q3 2025.
  • In the past 5 years, Dolby Laboratories' Liabilities and Shareholders Equity registered a high of $3.2 billion during Q1 2025, and its lowest value of $2.7 billion during Q3 2022.
  • In the last 5 years, Dolby Laboratories' Liabilities and Shareholders Equity had a median value of $3.1 billion in 2021 and averaged $3.0 billion.
  • Its Liabilities and Shareholders Equity has fluctuated over the past 5 years, first crashed by 1339.93% in 2022, then skyrocketed by 1079.06% in 2023.
  • Over the past 5 years, Dolby Laboratories' Liabilities and Shareholders Equity (Quarter) stood at $3.1 billion in 2021, then decreased by 11.48% to $2.7 billion in 2022, then increased by 6.8% to $2.9 billion in 2023, then rose by 7.6% to $3.2 billion in 2024, then grew by 1.06% to $3.2 billion in 2025.
  • Its Liabilities and Shareholders Equity stands at $3.2 billion for Q4 2025, versus $3.2 billion for Q3 2025 and $3.2 billion for Q2 2025.